Sajid Ali - Researcher Profile | RDL Research Database

Publications

3 shown

Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma

Ghassan K. Abou‐Alfa , George Lau , Masatoshi Kudo +28 more

BACKGROUND: A single, high priming dose of tremelimumab (anti-cytotoxic T lymphocyte–associated antigen 4) plus durvalumab (anti–programmed cell death ligand-1), an infusion reg...

2022 NEJM Evidence 1193 citations

Explainable Artificial Intelligence (XAI): What we know and what is left to attain Trustworthy Artificial Intelligence

Sajid Ali , Tamer Abuhmed , Shaker El–Sappagh +7 more

2023 Information Fusion 1124 citations

Aspergillus Welwitschiae Regulates Response of Wheat at Multiple Levels To Alleviate Induced Chromate Stress

Urooj Jamal , Zia Ur Rahman , Muhammad Qadir +3 more

2025 Current Microbiology 0 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 3
Citations: 2,317
Institution: AstraZeneca (Japan)

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-1287-849X

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.